Roughly a year after starting to invest in the company, Julian Robertson (Trades, Portfolio) has chopped half his stake in Enzymotec Ltd. (NASDAQ:ENZY), a maker of nutritional ingredients and medical foods.
Robertson sold 565,738 shares in the company on July 1, retaining 577,407 shares, or 2.5% of the company. He had started an Enzymotec position in the third quarter of 2015 with 804,854 shares, and increased it to 1,162,854 shares the next quarter, making him fourth largest shareholder. The stake brought him little if any return, trading for an average of $9 during his original purchase and around $8 for his recent sell. Enzymotec ended the trailing 12 months down 5% and is down 13% year to date. Continue Reading »